Abstract

Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2018 - Volume 22, Number 3

Page(s): 238

Download in electronic PDF format for $75
  • Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Abstract

A formulation for preparing Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • simvastatin
  • hyperlipidemia
  • blood cholesterol
  • plasma lipoproteins
  • immunomodulatory agent
  • MHC II

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2018
Pg. 238
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 367-369
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2021
Pg. 412
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 140
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 491
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 147
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 407
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 492
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 493
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 134
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 55
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 233
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 409
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr